Tuesday, August 20, 2024 4:46:07 PM
Yes that's been their MO for a few months now. ASCM is running interference for someone who's interest's are in conflict with those of our own, and I would add, RDGL's management. They appeared as a RDGL MARKET MAKER for the first time this current year 5 months ago back in APRIL (ASCM was no where to be found the first 3 months of this year). There is a .15 cent share offering out there that has not been aggressively shopped around imho. I couldn't imagine some entity, or individual, interested in this offering trying to cap the upside of the PPS in hopes of getting a more lucrative entry point by creating unwarranted pressure on the stocks PPS (Add sarcasm). Shorting maybe, or is it just an effort to create the artificial perception that there is resistance to the upside? The trading strategy here with ASCM does not have the appearance of being organic in nature or a random event. Absent of ASCM RDGL would currently be traded at a much higher PPS. They are the only real resistance here no and's, if's, buts, or maybe's. The current drag on the PPS facilitated by this certain MARKET MAKER has very little to do with any uncertainty surrounding FDA resubmission (That could very easily be any day now) and a whole lot to do with ASCM's presence here and the underlying reason for such....ASCM does move rather easy and with little resistance when having their artificial non organic ASK hit. And yes it couldn't be more obvious that ASCM doesn't like being placed second on the RDGL BIDDERS list.....Hard for the fox to be guarding the hen house if he's not being allowed access. Or in this case opportunity.....
Never buy a stock based on my opinion of that stock.Form your own opinion by doing your own DD.My position on any stock I buy can change without notice.I am not a licensed broker or stock adviser and I really don't know what I'm doing.
Recent RDGL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
